迈得医疗涨2.24%，成交额2617.97万元，主力资金净流入60.86万元

Core Viewpoint - Midea Medical has shown significant stock performance with an 85.93% increase year-to-date, indicating strong market interest and potential growth in the medical equipment sector [1][2]. Financial Performance - As of June 30, 2025, Midea Medical reported a revenue of 141 million yuan, a year-on-year decrease of 14.75%, and a net profit of 6.0451 million yuan, down 38.81% compared to the previous year [2]. - The company has distributed a total of 202 million yuan in dividends since its A-share listing, with 99.2975 million yuan distributed over the last three years [3]. Stock Market Activity - Midea Medical's stock price reached 20.08 yuan per share, with a trading volume of 26.1797 million yuan and a turnover rate of 0.80% [1]. - The stock has experienced a net inflow of 608,600 yuan from major funds, with significant buying activity from large orders [1]. Shareholder Information - As of June 30, 2025, the number of shareholders decreased by 4.80% to 3,805, while the average number of circulating shares per person increased by 5.05% to 43,684 shares [2]. - Notable shareholders include 华夏行业景气混合A and 华夏远见成长一年持有混合A, with the former maintaining its position and the latter being a new entrant among the top shareholders [3]. Business Overview - Midea Medical, established on March 10, 2003, and listed on December 3, 2019, specializes in the research, production, sales, and service of medical consumables and intelligent equipment [1]. - The company's main revenue sources include safety infusion connection machines (42.18%), blood purification connection machines (37.90%), and safety infusion single machines (14.04%) [1].